Patents by Inventor Marc Gomez Caminals

Marc Gomez Caminals has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9216208
    Abstract: A topical ophthalmic formulation of peptides and their use for the treatment and/or local prevention of ocular diseases, preferably posterior segment eye diseases.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: December 22, 2015
    Assignee: BCN Peptides, S.A.
    Inventors: Rafael Simó Canonge, Cristina Hernández Pascual, Jimena Fernández Carneado, Marc Gómez Caminals, Rlbera Jordana I Lluch, Josep Farrera Sinfreu, Berta Ponsati Obiols
  • Patent number: 8946154
    Abstract: Peptide derivatives, their stereoisomers, mixtures thereof and/or their pharmaceutically acceptable salts, a method of obtaining them, pharmaceutical compositions containing them and the use thereof for the treatment, prevention and/or diagnosis of those conditions, disorders and/or pathologies in which the sstr1, sstr2, sstr3, sstr4 and/or sstr5 somatostatin receptors are expressed.
    Type: Grant
    Filed: May 6, 2010
    Date of Patent: February 3, 2015
    Assignee: BCN Peptides, S.A.
    Inventors: Antonio Parente Dueña, Berta Ponsati Obiols, Jimena Fernández Carneado, Marc Gómez Caminals, Ribera Jordana I Lluch
  • Publication number: 20130210728
    Abstract: A topical ophthalmic formulation of peptides and their use for the treatment and/or local prevention of ocular diseases, preferably posterior segment eye diseases.
    Type: Application
    Filed: December 17, 2010
    Publication date: August 15, 2013
    Applicant: BCN PEPTIDES, S.A.
    Inventors: Rafael Simó Canonge, Cristina Hernández Pascual, Jimena Fernández Carneado, Marc Gómez Caminals, RIbera Jordana I Lluch, Josep Farrera Sinfreu, Berta Ponsati Obiols
  • Publication number: 20120122781
    Abstract: Peptide derivatives, their stereoisomers, mixtures thereof and/or their pharmaceutically acceptable salts, a method of obtaining them, pharmaceutical compositions containing them and the use thereof for the treatment, prevention and/or diagnosis of those conditions, disorders and/or pathologies in which the sstr1, sstr2, sstr3, sstr4 and/or sstr5 somatostatin receptors are expressed.
    Type: Application
    Filed: May 6, 2010
    Publication date: May 17, 2012
    Applicant: BCN PEPTIDES, S.A.
    Inventors: Antonio Parente Duena, Berta Ponsati Obiols, Jimena Fernandez Carneado, Marc Gomez Caminals, Ribera Jordana I Lluch